Rothenberg Out at Embattled Turing
Wed., Sep. 23, 2015
By Greg Hazley
Craig Rothenberg, the veteran Johnson & Johnson communications exec who moved to embattled Turing Pharmaceuticals in July, has left the company.
Turing is facing questions after it raised the price of a drug for cancer and HIV patients 5,000%.
Rothenberg has opened his own shop, Rothenberg Communications, based in Short Hills, N.J.
Alan Ripp of Ripp Media is supporting the company's PR in the crisis.
CEO Martin Shkreli reversed course on Tuesday and said the company would roll back the price increase of Daraprim.
Category: Healthcare PR
More Healthcare PR posts from O'Dwyer's:
• | Real Chemistry’s Isidro Shifts NarrativeWed., Feb. 28, 2024 |
• | Fernandez Takes Healthcare Post in BerkshiresMon., Jan. 15, 2024 |
• | Weber Shandwick Alum Bargar Joins GCI HealthThu., Dec. 14, 2023 |
• | JPA Health to Support National SAMHSA CampaignThu., Oct. 26, 2023 |
• | The Essential Elements of Thought LeadershipMon., Oct. 23, 2023 |
No comments have been submitted for this story yet.